Jérôme Bertherat Selected Research

Pituitary Irradiation

4/2011	Pregnancy does not accelerate corticotroph tumor progression in Nelson's syndrome.
1/2007	Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jérôme Bertherat Research Topics

Disease

75	Neoplasms (Cancer) 08/2022 - 01/2002
48	Cushing Syndrome 08/2022 - 05/2002
29	Hyperplasia 05/2022 - 05/2002
24	Adenoma (Adenomas) 01/2022 - 05/2002
22	Adrenocortical Carcinoma 04/2022 - 08/2003
16	Paraganglioma (Paragangliomas) 01/2022 - 03/2006
16	Pheochromocytoma 01/2022 - 03/2006
14	Pituitary ACTH Hypersecretion 08/2020 - 01/2004
12	Adrenocortical Adenoma (Disease, Conn's) 01/2021 - 08/2003
12	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2018 - 11/2002
11	Carney Complex 11/2020 - 12/2002
11	Carcinogenesis 12/2012 - 12/2002
9	Acth-Independent Macronodular Adrenal Hyperplasia 11/2013 - 05/2002
6	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022 - 05/2008
5	Hypertension (High Blood Pressure) 01/2022 - 03/2009
4	Carcinoma (Carcinomatosis) 12/2018 - 03/2005
3	ACTH-Secreting Pituitary Adenoma 01/2021 - 01/2009
3	Myxoma (Myxomas) 11/2020 - 05/2006
3	Hyperaldosteronism (Conn Syndrome) 09/2020 - 02/2014
3	Adrenal Gland Neoplasms (Adrenal Cancer) 01/2018 - 08/2003
3	Neoplasm Metastasis (Metastasis) 01/2017 - 06/2004
2	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 03/2022 - 11/2019
2	Cardiac Arrhythmias (Arrythmia) 01/2022 - 01/2006
2	Headache (Headaches) 08/2020 - 08/2015
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2019 - 06/2013
2	Addison Disease (Addison's Disease) 02/2018 - 12/2017
2	Disease Progression 01/2016 - 03/2007
2	Hypogonadism (Hypergonadotropic Hypogonadism) 05/2013 - 01/2013
2	Pituitary Neoplasms (Pituitary Adenoma) 10/2012 - 01/2009
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2011 - 12/2010
2	Acromegaly 07/2007 - 06/2006
2	Beckwith-Wiedemann Syndrome (Exomphalos Macroglossia Gigantism Syndrome) 11/2006 - 10/2005
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 03/2022
1	Osteoporosis 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Pulmonary Edema 01/2022

Drug/Important Bio-Agent (IBA)

36	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2022 - 05/2002
30	Adrenocorticotropic Hormone (ACTH)FDA Link 08/2022 - 05/2002
15	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2002
14	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2020 - 12/2002
13	SteroidsIBA 08/2022 - 01/2002
13	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2005
12	GlucocorticoidsIBA 08/2022 - 05/2008
10	EnzymesIBA 08/2022 - 03/2005
8	Mitotane (Lysodren)FDA Link 12/2018 - 07/2006
8	Succinate Dehydrogenase (Fumarate Reductase)IBA 06/2015 - 03/2006
8	CateninsIBA 06/2015 - 11/2010
7	CatecholaminesIBA 01/2022 - 01/2002
7	Messenger RNA (mRNA)IBA 01/2018 - 12/2002
7	Cyclic AMP (AMP, Cyclic)IBA 09/2009 - 01/2002
6	AldosteroneIBA 01/2021 - 06/2004
6	beta CateninIBA 01/2021 - 09/2005
6	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2018 - 01/2002
6	Peptides (Polypeptides)IBA 01/2017 - 03/2006
5	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2013 - 07/2006
4	gastric inhibitory polypeptide receptorIBA 01/2022 - 05/2002
4	Biological ProductsIBA 01/2017 - 07/2006
4	Carrier Proteins (Binding Protein)IBA 07/2012 - 11/2002
3	AndrogensIBA 08/2022 - 07/2006
3	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 08/2022 - 01/2010
3	Dexamethasone (Maxidex)FDA LinkGeneric 03/2022 - 10/2009
3	Hormones (Hormone)IBA 01/2022 - 11/2002
3	Protein Isoforms (Isoforms)IBA 01/2019 - 05/2002
3	Serotonin (5 Hydroxytryptamine)IBA 09/2016 - 11/2006
3	MetanephrineIBA 01/2016 - 10/2007
2	OsilodrostatIBA 08/2022 - 05/2021
2	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 08/2022 - 09/2020
2	MineralocorticoidsIBA 08/2022 - 02/2018
2	ParaffinIBA 04/2022 - 08/2015
2	LipidsIBA 01/2022 - 09/2015
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2019
2	P-2 (P 2)IBA 01/2019 - 03/2009
2	Etoposide (VP 16)FDA LinkGeneric 12/2018 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2018 - 01/2006
2	Steroidogenic Factor 1IBA 01/2017 - 02/2012
2	NormetanephrineIBA 01/2016 - 05/2012
2	Progesterone FDA LinkGeneric 12/2015 - 06/2008
2	pasireotideIBA 10/2015 - 01/2012
2	Insulin-Like PeptidesIBA 01/2014 - 11/2006
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2010 - 01/2003
2	LigandsIBA 09/2010 - 03/2009
2	Metoclopramide (Reglan)FDA LinkGeneric 03/2009 - 01/2003
2	aryl hydrocarbon receptor-interacting proteinIBA 01/2009 - 07/2007
2	Adenosine (Adenocard)FDA LinkGeneric 10/2008 - 08/2003
2	Phosphotransferases (Kinase)IBA 05/2008 - 07/2003
2	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 11/2006 - 03/2005
2	ElementsIBA 07/2006 - 08/2003
1	LyasesIBA 08/2022
1	Metyrapone FDA Link 08/2022
1	Explosive Agents (Explosives)IBA 08/2022
1	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 08/2022
1	Cosyntropin (Cortrosyn)FDA LinkGeneric 08/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022

Therapy/Procedure

12	Therapeutics 01/2021 - 09/2005
10	Adrenalectomy 01/2021 - 01/2004
3	Drug Therapy (Chemotherapy) 12/2018 - 03/2007
2	Pancreatectomy 12/2019 - 10/2019
2	Ligation 01/2017 - 01/2013
2	Pituitary Irradiation 04/2011 - 01/2007